Demant gets FDA green light for new bone-anchored hearing solution

Oticon Medical, Demant's implants arm, has had its new bone-anchored product, Ponto 5 Superpower, cleared in the US. Following the FDA approval, the device is expected to be on shelves in spring.
The FDA has cleared Oticon's new product, Ponto 5 Superpower, which is a Bone Anchored Hearing System (BAHS) | Photo: Jens Dresling/Politiken/Ritzau Scanpix
The FDA has cleared Oticon's new product, Ponto 5 Superpower, which is a Bone Anchored Hearing System (BAHS) | Photo: Jens Dresling/Politiken/Ritzau Scanpix
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen

The US Food and Drug Administration (FDA) has cleared Oticon Medical, Demant's implants arm, to market and sell its newest bone anchored hearing system (BAHS), a company press release announces.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading